The countersuit, filed Aug. 5 in the Western District of Missouri, comes after BCBS of Kansas City filed a lawsuit against GS Labs July 21 alleging it had filed $9.2 million in inflated claims related to COVID-19 testing.
The payer claimed GS Labs had charged $380 for tests that were a wholesale price of $20.
GS Labs said in its countersuit that it had published the $380 fee for its rapid antigen tests online in accordance with the CARES Act.
“Blue KC’s reference to alleged wholesale prices demonstrates its underlying contempt for the valuable services that GS Labs provided,” court documents obtained by KSHB said.
GS Labs also said Blue KC violated the CARES Act by refusing to pay for COVID-19 testing.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
